Skip to main content

Table 5 Change in outcome measures from beginning to end of study

From: Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]

  N-acetylcysteine (n = 25) Placebo (n = 25)
Likert Score 0.7 0.8
FEV 1 (litres) 0.03 0.15
Sa0 2 (%) 1.2 1.8
  1. The average change in Likert score, FEV1, VC and SaO2 from entry into the study to end of study (discharge or Day 7) are shown.